semaglutide fda approval Approves Oral as the First Oral GLP-1 Pill Oral Semaglutide Gets FDA Approval

Thats why Digest includes ingredients that support neurotransmitters and nervous system communication

GLP-1 RAs are known to delay gastric emptying and can exacerbate constipation, particularly in patients with pre-existing risk factors, such as prior abdominal surgery, adhesive disease, cirrhosis with ascites, and the use of multiple constipating medications

As such, the FDA has since approved SGLT2i to reduce the risk of kidney function decline in both diabetic and non-diabetic patients with CKD

The source of pharmaceutical-grade semaglutide is tightly regulated

Driven by advancements in semaglutide formulations and an increased emphasis on medically supervised programs, healthcare providers and patients alike are navigating new standards for safety, access, and long-term metabolic support